Indenone derivatives:: A novel template for peroxisome proliferator-activated receptor γ (PPARγ) agonists

被引：124
|
作者：
Ahn, Jin Hee
Shin, Mi Sik
Jung, Sun Ho
Kang, Seung Kyu
Kim, Kwang Rok
Rhee, Sang Dal
Jung, Won Hoon
Yang, Sung Don
Kim, Seung Jun
Woo, Joo Rang
Lee, Jeong Hyung
Cheon, Hyae Gyeong [1 ]
Kim, Sung Soo
机构：
[1] Korea Res Inst Chem Technol, Bioorgan Sci Div, Taejon 305600, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 15期
关键词：
D O I：
10.1021/jm060389m
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Agonists of peroxisome proliferator-activated receptor gamma (PPAR gamma) are of interest as a treatment for diabetes, which prompted the identification of a new class of non-TZD PPAR gamma agonist. Moreover, compound 14c has displayed the most active agonistic activity with an EC50 value of 50 nM, in addition to exhibiting a new binding mode in the X-ray cocrystal structure.
引用
收藏
页码：4781 / 4784
页数：4
相关论文
共 50 条
  • [21] The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists
    Matin, Azadeh
    Doddareddy, Munikumar Reddy
    Gavande, Navnath
    Nammi, Srinivas
    Groundwater, Paul W.
    Roubin, Rebecca H.
    Hibbs, David E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (03) : 766 - 778
  • [22] Evidence for peroxisome proliferator-activated receptor (PPAR)α-independent peroxisome proliferation:: Effects of PPARγ/δ-specific agonists in PPARα-Null mice
    DeLuca, JG
    Doebber, TW
    Kelly, LJ
    Kemp, RK
    Molon-Noblot, S
    Sahoo, SP
    Ventre, J
    Wu, MS
    Peters, JM
    Gonzalez, FJ
    Moller, DE
    MOLECULAR PHARMACOLOGY, 2000, 58 (03) : 470 - 476
  • [23] Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
    Wang, Limei
    Waltenberger, Birgit
    Pferschy-Wenzig, Eva-Maria
    Blunder, Martina
    Liu, Xin
    Malainer, Clemens
    Blazevic, Tina
    Schwaiger, Stefan
    Rollinger, Judith M.
    Heiss, Elke H.
    Schuster, Daniela
    Kopp, Brigitte
    Bauer, Rudolf
    Stuppner, Hermann
    Dirsch, Verena M.
    Atanasov, Atanas G.
    BIOCHEMICAL PHARMACOLOGY, 2014, 92 (01) : 73 - 89
  • [24] Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders
    Seminotti, Bianca
    Grings, Mateus
    Vockley, Jerry
    Leipnitz, Guilhian
    BIOCHEMICAL PHARMACOLOGY, 2023, 209
  • [25] Role of peroxisome proliferator-activated receptor (PPAR) agonists in experimental liver fibrosis in rats
    Ghoneim, MT
    El-Azim, TA
    Baraka, AM
    Matta, MM
    El-Din, NMN
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R89 - R89
  • [26] Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Giampietro, Letizia
    Amoroso, Rosa
    CHEMMEDCHEM, 2013, 8 (10) : 1609 - 1616
  • [27] Peroxisome proliferator-activated receptor (PPAR) α and γ agonists directly bind and close KATP channel
    Shimomura, K
    Shimizu, H
    Ikeda, M
    Matsumoto, S
    Mori, M
    DIABETES, 2003, 52 : A369 - A369
  • [28] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
    Ioannis A. Voutsadakis
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 917 - 928
  • [29] ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-α IN SEPSIS
    Standage, S.
    Odoms, K.
    Denenberg, A.
    Zingarelli, B.
    Wong, H.
    SHOCK, 2010, 33 : 10 - 10
  • [30] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
    Voutsadakis, Ioannis A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (12) : 917 - 928
12345